Lifeway Foods Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
12.9%projected annual EPS growth
Analyst Coverage
2analysts covering
FY Revenue (est.)
$251.5Mnext fiscal year
FY EPS (est.)
$1.11next fiscal year
Reporting Calendar
| Event | Expected Date |
|---|---|
| Q3 2026 Earnings Release | 12 Nov 2026 |
Monitoring Framework
Key Performance Indicators
Net Sales Quarterly63MTarget: Strongest annual sales in company history for FY 2026
Gross Profit Margin Quarterly2,750.0%Target: Continued expansion through manufacturing efficiency and favorable milk pricing
Adjusted EBITDA AnnuallyTarget: $45,000,000 to $50,000,000 by FY 2027
Watch Items
- Waukesha, Wisconsin Facility Capacity Expansion (Phase 2)Trigger: Completion of the remaining three stages of expansionAction: Monitor progress toward the expected completion in Q3 2026 to double production capacity and support the Wisconsin dairy economy.
- Danone Stake Divestment and Relationship SeparationTrigger: Secondary underwritten public offering of 3.45 million shares at $19.50 eachAction: Track the completion of the $5 million share repurchase by Lifeway and the final resolution of historical litigation and governance disputes.
- New Product Commercialization (Muscle Mates and Probiotic Kefir Butter)Trigger: Nationwide retail distribution expansionAction: Evaluate sales volume contribution from newly launched functional dairy innovations targeting protein-rich and gut-health consumer trends.
Research as of 20 Jun 2026